Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001377380 | SCV001574700 | likely pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2020-02-05 | criteria provided, single submitter | clinical testing | This variant affects a cysteine residue in the EGF-like, TGFBP or hybrid motif domains of FBN1. Cysteine residues are believed to be involved in intramolecular disulfide bridges and have been shown to be important for FBN1 protein structure (PMID: 16905551, 19349279). In addition, missense substitutions affecting cysteine residues within these domains are significantly overrepresented among patients with Marfan syndrome (PMID: 16571647, 17701892). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Cys617 amino acid residue in FBN1. Other variant(s) that disrupt this residue have been observed in individuals with FBN1-related conditions (PMID: 29357934), which suggests that this may be a clinically significant amino acid residue. This variant has been observed in individual(s) with clinical features of Marfan syndrome (Invitae). This variant is not present in population databases (ExAC no frequency). This variant, c.1849_1851del, results in the deletion of 1 amino acid(s) of the FBN1 protein (p.Cys617del), but otherwise preserves the integrity of the reading frame. |